Amgen Inc (NASDAQ:AMGN)

170.17
Data as of Dec 19
 +1.69 / +1.00%
Today’s Change
108.20
Today|||52-Week Range
173.14
+49.17%
Year-to-Date
Why Is George Soros Buying This Beaten Down Biotech Stock?
11:05am / MotleyFool.com
Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson
Dec 15 / MotleyFool.com
Agenus Jumps on Positive Data from Shingles Candidate - Analyst Blog
Dec 19 / Zacks.com
bluebird bio (BLUE) Soars on Data from LentiGlobin Study - Analyst Blog
Dec 11 / Zacks.com
Seattle Genetics Initiates Phase Ib Study on Leukemia Drug - Analyst Blog
Dec 19 / Zacks.com
Mylan Among First to Launch Generic Celebrex - Analyst Blog
Dec 11 / Zacks.com
Second time lucky in biotech shares
Dec 19 / FT.com
Can Pfizerbs Cholesterol Drug Catch Up To The Competition?
Dec 11 / MotleyFool.com
Halozyme Up on Collaboration and Licensing Deal with J&J - Analyst Blog
Dec 18 / Zacks.com
Biotech Stock Roundup: Cubist to be Acquired by Merck, Bluebird Shoots Up on ASH Data...
Dec 10 / Zacks.com
Novartis Successfully Expands Signifor Label in the U.S. - Analyst Blog
Dec 17 / Zacks.com
AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH (Revised) - Analyst Blog
Dec 10 / Zacks.com
Alkermes Starts Phase I Study on Schizophrenia Candidate - Analyst Blog
Dec 16 / Zacks.com
Dynavax & AstraZeneca Alter Agreement for Asthma Product - Analyst Blog
Dec 09 / Zacks.com
Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst Blog
Dec 16 / Zacks.com
Alnylam Reports Positive Initial Phase I Data on ALN-AT3 - Analyst Blog
Dec 09 / Zacks.com
Acorda's Ampyra in Phase III for Post-Stroke Walking Deficit - Analyst Blog
Dec 16 / Zacks.com
Pharmacyclics Presents Imbruvica Data at the ASH Meeting - Analyst Blog
Dec 09 / Zacks.com
OPKO Up on Announcing Global Partnership with Pfizer - Analyst Blog
Dec 16 / Zacks.com
Amgen Successfully Expands Xgeva Label in the U.S. - Analyst Blog
Dec 09 / Zacks.com
2 Names Top My Watch List
Dec 16 / TheStreet.com
Celgene Up on Positive Revlimid Data Presented at ASH - Analyst Blog
Dec 09 / Zacks.com
High-Octane Tech ETFs For 2015
Dec 16 / Investing Channel
Novartis Reports Encouraging Data on Biosimilar of Neupogen - Analyst Blog
Dec 09 / Zacks.com
4 Top Ranked Biotech Stocks that Beat the Market in 2014 - Analyst Blog
Dec 16 / Zacks.com
3 Reasons Amgen, Inc. Could Soar in 2015
Dec 09 / MotleyFool.com
Amgen Just Crashed 50% In Premarket, Here's How It Looked
Dec 16 / Benzinga
Amgen Unveils Positive Results from Blood Cancer Studies - Analyst Blog
Dec 08 / Zacks.com
Stock Market News for December 16, 2014 - Market News
Dec 16 / Zacks.com
Pharmacyclics (PCYC) Launches U.S.-Based CLL Registry - Analyst Blog
Dec 08 / Zacks.com
Early Morning Activity Shows Amgen (AMGN) Down
Dec 16 / TheStreet.com
ImmunoGen Reports Encouraging Data on Cancer Drug - Analyst Blog
Dec 08 / Zacks.com
A Shift From Healthcare To Discretionary
Dec 16 / StockTwits
Seattle Genetics-Takeda's Adcetris Shows Long-Term Effect - Analyst Blog
Dec 08 / Zacks.com
Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog
Dec 15 / Zacks.com
AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH - Analyst Blog
Dec 08 / Zacks.com
Jazz Pharmaceuticals Starts Defibrotide Rolling NDA Filing - Analyst Blog
Dec 15 / Zacks.com
US oil stocks drop as crude prices slide
Dec 08 / FT.com
Alnylam Provides Pipeline Update, Growth Strategy - Analyst Blog
Dec 15 / Zacks.com
3 Biotech Companies That Are Making Incredibly Smart Moves
Dec 08 / MotleyFool.com
Puma Biotechnology Reveals Positive Interim PB272 Data - Analyst Blog
Dec 15 / Zacks.com
Loeb wins battle to appoint Dow Chemical directors
Nov 21 / FT.com
Former Onyx CEO Returns to Biotech to Launch Boston Start Up
Dec 15 / TheStreet.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.